Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study
10.1182/bloodadvances.2022006960
Saved in:
| Main Authors: | , , , , , , , , , |
|---|---|
| Other Authors: | |
| Format: | Article |
| Language: | English |
| Published: |
ELSEVIER
2023
|
| Subjects: | |
| Online Access: | https://scholarbank.nus.edu.sg/handle/10635/237840 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| Institution: | National University of Singapore |
| Language: | English |
| id |
sg-nus-scholar.10635-237840 |
|---|---|
| record_format |
dspace |
| spelling |
sg-nus-scholar.10635-2378402024-04-17T09:36:06Z Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study Jang, Jun Ho Wong, Lily Ko, Bor-Sheng Yoon, Sung-Soo Li, Katie Baltcheva, Irina Nidamarthy, Prasanna Kumar Chawla, Raghav Junge, Guido Yap, Eng Soo MEDICINE Science & Technology Life Sciences & Biomedicine Hematology COMPLEMENT INHIBITOR ECULIZUMAB FACTOR B INHIBITOR HEMOLYSIS PHASE-3 10.1182/bloodadvances.2022006960 BLOOD ADVANCES 6 15 4450-4460 2023-03-03T04:09:41Z 2023-03-03T04:09:41Z 2022-08-02 2023-03-03T03:21:18Z Article Jang, Jun Ho, Wong, Lily, Ko, Bor-Sheng, Yoon, Sung-Soo, Li, Katie, Baltcheva, Irina, Nidamarthy, Prasanna Kumar, Chawla, Raghav, Junge, Guido, Yap, Eng Soo (2022-08-02). Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study. BLOOD ADVANCES 6 (15) : 4450-4460. ScholarBank@NUS Repository. https://doi.org/10.1182/bloodadvances.2022006960 2473-9529 24739537 https://scholarbank.nus.edu.sg/handle/10635/237840 en ELSEVIER Elements |
| institution |
National University of Singapore |
| building |
NUS Library |
| continent |
Asia |
| country |
Singapore Singapore |
| content_provider |
NUS Library |
| collection |
ScholarBank@NUS |
| language |
English |
| topic |
Science & Technology Life Sciences & Biomedicine Hematology COMPLEMENT INHIBITOR ECULIZUMAB FACTOR B INHIBITOR HEMOLYSIS PHASE-3 |
| spellingShingle |
Science & Technology Life Sciences & Biomedicine Hematology COMPLEMENT INHIBITOR ECULIZUMAB FACTOR B INHIBITOR HEMOLYSIS PHASE-3 Jang, Jun Ho Wong, Lily Ko, Bor-Sheng Yoon, Sung-Soo Li, Katie Baltcheva, Irina Nidamarthy, Prasanna Kumar Chawla, Raghav Junge, Guido Yap, Eng Soo Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| description |
10.1182/bloodadvances.2022006960 |
| author2 |
MEDICINE |
| author_facet |
MEDICINE Jang, Jun Ho Wong, Lily Ko, Bor-Sheng Yoon, Sung-Soo Li, Katie Baltcheva, Irina Nidamarthy, Prasanna Kumar Chawla, Raghav Junge, Guido Yap, Eng Soo |
| format |
Article |
| author |
Jang, Jun Ho Wong, Lily Ko, Bor-Sheng Yoon, Sung-Soo Li, Katie Baltcheva, Irina Nidamarthy, Prasanna Kumar Chawla, Raghav Junge, Guido Yap, Eng Soo |
| author_sort |
Jang, Jun Ho |
| title |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| title_short |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| title_full |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| title_fullStr |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| title_full_unstemmed |
Iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| title_sort |
iptacopan monotherapy in patients with paroxysmal nocturnal hemoglobinuria: a 2-cohort open-label proof-of-concept study |
| publisher |
ELSEVIER |
| publishDate |
2023 |
| url |
https://scholarbank.nus.edu.sg/handle/10635/237840 |
| _version_ |
1800915792009625600 |